Online Reporter
IN recent months, the healthcare landscape in Zimbabwe has faced unprecedented challenges, particularly in the distribution of essential medicines to hospitals.
While the medicines are readily available and stocked in the country, patients in public hospitals are often left waiting for critical drugs, while healthcare providers struggle to meet the needs of those relying on their services.
This was one of the issues noted by President Mnangagwa when he recently made an unannounced visit to major hospitals in Harare and the National Pharmaceutical Company (NatPharm)’s warehouse.
The President wanted to get a first-hand appreciation of the problems affecting the health delivery system.
It is imperative, then, that these issues are addressed head-on, and NatPharm, as the primary distributor of pharmaceuticals in the country, must take the lead in implementing effective distribution solutions.
The state of medicine distribution is not merely an inconvenience; it poses serious risks to patient health and well-being.
Hospitals are reporting stockouts of vital drugs, leading to increased morbidity and mortality rates, when they could be adequately supplied if the distribution systems were up to scratch.
This situation is unacceptable, especially when one considers the dedication of healthcare workers and the vulnerability of the population.
The failure to have an efficient distribution system from NatPharm to hospitals can lead to serious health complications, increased hospitalisations and even preventable deaths.
Moreover, healthcare professionals, who work tirelessly to provide care, face immense pressure when they cannot adequately treat their patients.
Frustration mounts as doctors and nurses are left to explain shortages to their patients, often with no clear answers, when in actual fact the medicines are readily available at NatPharm.
This erosion of trust can have long-term implications for public confidence in the healthcare system as a whole.
It is then imperative for NatPharm to enhance its supply chain management by making it robust.
By utilising technology to track inventory levels in real time, NatPharm can actually ensure that hospitals are adequately stocked with the necessary medications.
Investing in software that integrates data from various healthcare facilities can provide a comprehensive view of medication needs across the country.
Another solution could be for NatPharm to establish stronger partnerships with hospitals and clinics to identify their specific needs.
A collaborative approach will ensure that distribution is aligned with the actual requirements of healthcare providers, while joint planning sessions between NatPharm and healthcare administrators can help align resources and expectations.
Instead of mourning about its problems with infrastructure for transportation of the medicines to health institutions, NatPharm must start investing in an efficient distribution network.
Establishing a feedback loop with healthcare facilities will allow NatPharm to quickly address any emerging issues.
Regular surveys and open lines of communication can provide valuable insights into the challenges faced by hospitals and enable NatPharm to respond proactively.
To effectively implement these solutions, it is crucial for NatPharm to constantly engage all relevant stakeholders, including Government agencies, healthcare institutions and healthcare professionals.
Collaborative efforts can yield innovative approaches to overcoming the challenges faced in medicine distribution.
Furthermore, international partnerships can offer valuable lessons. Learning from successful models in other countries can provide insights into best practices that can be adapted to fit the unique context of Zimbabwe in the distribution of medicines.
The Government has been playing a crucial role in supporting NatPharm’s initiatives by prioritising healthcare funding to ensure that sufficient resources are allocated for the procurement and distribution of medicines.
The health of the nation depends on the effectiveness of the healthcare system, and timely access to medicines is a critical component.
As we advocate for these changes, we urge NatPharm to recognise the urgency of the situation and act decisively by implementing solutions that address the bottlenecks in the medicines supply chain.
But the responsibility of improving medicine distribution does not rest solely on NatPharm; it is a collective effort that requires collaboration among all stakeholders.
It is important that the Ministry of Health and Child Care has stepped in to take the responsibility of assisting NatPharm in addressing the challenges it is facing with the distribution of medicines.
We expect Treasury to complement these efforts by releasing funds to public hospitals timeously for them to replenish their stocks without causing discomfort to patients, who have to resort to expensive private pharmacies.
Online Reporter